Jennifer C. Woo

发表

Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV

H. Balfour, J. Cohen, Hui Liu, 2016, Clinical and Vaccine Immunology.

Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A

Chin-fen Yang, H. Jin, Jennifer C. Woo, 2012, PloS one.

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.

R. Belshe, X. Wu, C. Ambrose, 2010, Vaccine.

A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation

C. McCrae, A. Hajjar, A. Tovchigrechko, 2015, PloS one.

Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.

A. Cherukuri, Jennifer C. Woo, Esteban G Servat, 2012, Vaccine.

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

K. Coelingh, Jennifer C. Woo, Allyn Bandell, 2011, Expert review of vaccines.

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2022, PLoS pathogens.

Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2022, bioRxiv.

Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.

R. Lin, Michael P. McCarthy, E. Rao, 2016, Vaccine.

Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines

C. Ambrose, Jennifer C. Woo, 2009, Influenza and other respiratory viruses.

Infection of Fibroblasts and Epithelial Cells Neutralizing Antibodies That Prevent Cellular Immune Responses and Broad Towne-Derived Dense Bodies Induce Cytomegalovirus Vaccine Strain

Janine Lu, G. Duke, G. Nest, 2014 .

Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells

H. Jin, Janine Lu, G. Duke, 2013, Journal of Virology.

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

P. Goepfert, M. Piepenbrink, L. Martínez-Sobrido, 2020, bioRxiv.

A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models

Jennifer C. Woo, E. Stillman, S. Lambert, 2015, PloS one.

Plasmablast-derived polyclonal antibody response after influenza vaccination.

Mark M. Davis, C. Dekker, S. Sasaki, 2011, Journal of immunological methods.

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.

Wei Zhu, B. Jallal, G. Kemble, 2010, Vaccine.

674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105

Luisa Yee, W. Dummer, Jennifer C. Woo, 2019, Open Forum Infectious Diseases.

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine

H. Balfour, Hui Liu, G. Hayes, 2020, Mediterranean journal of hematology and infectious diseases.

Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo.

G. Hayes, E. Rao, L. Gemmell, 2015, Vaccine.